Time

Speaker

13:00 - 13:30

Reception

13:30 - 13:50

Opening Remarks

Dr. Shou-Mei Wu, Director General of Taiwan Food and Drug Administration 
Dr. Li-Tzong Chen, President of Taiwan Oncology Society
Dr. Ta-Sen Yeh, President of Taiwan Pancreas Society
Dr. Johnsee Lee, Chairman of Taiwan Bio Industry Organization
Dr. Muh-Hwan Su, General Manager of SynCore Biotechnology

Session Moderator: Dr. Ta-Sen Yeh, President of Taiwan Pancreas Society

13:50 - 14:20

The Experience of mFOLFIRINOX for Patients with Pancreatic Cancer

Dr. Li Yuan Bai
Director, Division of Hematology and Oncology, China Medical University Hospital, Taiwan

The Korea Experience of FOLFIRINOX in Pancreatic Cancer

Dr. Hong Jae Chon
Associate Professor, Medical Oncology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Gyeonggi-Do, Korea ​

14:50 - 15:10

Coffee Break

Session Moderator: Dr. Li-Tzong Chen, President of Taiwan Oncology Society

15:10 - 15:40

The U.S. Experience of FOLFIRINOX in Pancreatic Cancer

Dr. Philip Agop Philip
Karmanos Cancer Institute, Wayne State University,
Leader, GI and Neuroendocrine Oncology, Vice President of Medical Affairs USA

15:40 - 16:10

Retrospective Analysis of FOLFIRINOX Treatment in Advanced Pancreatic Cancer in Out Center

Dr. Zsuzsanna Pápai
Head of the Oncology Department, Medical Center- Hungarian Defense Forces, Budapest, Hungary

16:10 - 16:40

The France Experience of FOLFIRINOX in Pancreatic Cancer

Dr. Jean-Philippe Metges
Associate Professor & Oncology Physician, Institute of Oncology and Hematology, Brest CHRU, France

16:40 - 17:10

Panel Discussion

Dr. Li Yuan Bai, Director, China Medical University Hospital, Taiwan
Dr. Hong Jae Chon, Associate Professor, CHA Bundang Medical Centera, South Korea
Dr. Jean-Philippe Metges, Associate Professor, Brest CHRU, France
Dr. Philip Agop Philip, Vice President of Medical Affairs USA
Dr. Zsuzsanna Pápai, Head of Oncology Department, Hungary
​Dr. Li-Tzong Chen, President of Taiwan Oncology 
Dr. Ta-Sen Yeh, President of Taiwan Pancreas Society
Dr. Muh-Hwan Su, General Manager, SynCore Biotechnology